GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (UKEX:JNJ) » Definitions » Shiller PE Ratio

Johnson & Johnson (UKEX:JNJ) Shiller PE Ratio : 22.12 (As of May. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson Shiller PE Ratio?

As of today (2024-05-11), Johnson & Johnson's current share price is ₴5947.00. Johnson & Johnson's E10 for the quarter that ended in Mar. 2024 was ₴268.80. Johnson & Johnson's Shiller PE Ratio for today is 22.12.

The historical rank and industry rank for Johnson & Johnson's Shiller PE Ratio or its related term are showing as below:

UKEX:JNJ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.28   Med: 25.92   Max: 33.32
Current: 20.96

During the past years, Johnson & Johnson's highest Shiller PE Ratio was 33.32. The lowest was 19.28. And the median was 25.92.

UKEX:JNJ's Shiller PE Ratio is ranked better than
60% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs UKEX:JNJ: 20.96

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2024 was ₴53.035. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₴268.80 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Johnson & Johnson Shiller PE Ratio Historical Data

The historical data trend for Johnson & Johnson's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Shiller PE Ratio Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.45 31.45 29.88 28.15 21.67

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.91 26.23 21.48 21.67 22.12

Competitive Comparison of Johnson & Johnson's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.



Johnson & Johnson Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5947.00/268.8
=22.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=53.035/129.4194*129.4194
=53.035

Current CPI (Mar. 2024) = 129.4194.

Johnson & Johnson Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 59.763 100.560 76.915
201409 65.700 100.428 84.666
201412 35.225 99.070 46.016
201503 60.555 99.621 78.668
201506 63.721 100.684 81.907
201509 47.494 100.392 61.227
201512 45.515 99.792 59.028
201603 62.930 100.470 81.062
201606 56.597 101.688 72.032
201609 60.555 101.861 76.938
201612 54.618 101.863 69.394
201703 63.721 102.862 80.173
201706 55.410 103.349 69.387
201709 54.222 104.136 67.387
201712 -157.918 104.011 -196.495
201803 63.325 105.290 77.838
201806 57.389 106.317 69.860
201809 56.993 106.507 69.254
201812 44.328 105.998 54.123
201903 55.014 107.251 66.386
201906 82.323 108.070 98.586
201909 26.122 108.329 31.208
201912 59.368 108.420 70.867
202003 85.885 108.902 102.066
202006 53.827 108.767 64.047
202009 52.639 109.815 62.036
202012 25.726 109.897 30.296
202103 91.822 111.754 106.336
202106 93.009 114.631 105.008
202109 54.222 115.734 60.634
202112 70.054 117.630 77.075
202203 76.386 121.301 81.498
202206 71.241 125.017 73.750
202209 66.492 125.227 68.718
202212 52.639 125.222 54.404
202303 -1.187 127.348 -1.206
202306 77.574 128.729 77.990
202309 404.095 129.860 402.726
202312 66.096 129.419 66.096
202403 53.035 129.419 53.035

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Johnson & Johnson  (UKEX:JNJ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Johnson & Johnson Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (UKEX:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.